Single and multiple point <i>NRAS</i> mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients-Reference-Cited by-同舟云学术

Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients

Published:2022-09-01 Issue:13 Volume:63 Page:3237-3240
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Durinikova Anna¹²,Folta Adam¹^ORCID,Pardy Filip³,Svaton Jan¹³,Drncova Marie¹²^ORCID,Weinbergerova Barbora¹²^ORCID,Cetkovsky Petr⁴,Racil Zdenek⁴^ORCID,Jindra Pavel⁵,Szotkowski Tomas⁶,Zak Pavel⁷^ORCID,Mayer Jiri¹²³^ORCID,Jeziskova Ivana¹²^ORCID

Affiliation:

1. Department of Internal Medicine – Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

2. Department of Internal Medicine – Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

3. Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic

4. Institute of Hematology and Blood Transfusion, Prague, Czech Republic

5. Department of Hematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic

6. Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic

7. Department of Internal Medicine – Department of Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic

Funder

Ministry of Health of the Czech Republic

Ministry of Education, Youth and Sports of the Czech Republic

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2116931

Reference14 articles.

1. Implications of NRAS mutations in AML: a study of 2502 patients

2. Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia

3. Clinical and proteomic characterization of acute myeloid leukemia with mutatedRAS

4. Genomic Classification and Prognosis in Acute Myeloid Leukemia

5. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia